...
首页> 外文期刊>JAMA psychiatry >Association of Cohort and Individual Substance Use With Risk of Transitioning to Drug Use, Drug Use Disorder, and Remission From Disorder: Findings From the World Mental Health Surveys
【24h】

Association of Cohort and Individual Substance Use With Risk of Transitioning to Drug Use, Drug Use Disorder, and Remission From Disorder: Findings From the World Mental Health Surveys

机译:群组和个体物质的结合与毒品使用过渡的风险,药物使用障碍和紊乱的缓解:来自世界心理健康调查的调查结果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

ImportanceLimited empirical research has examined the extent to which cohort-level prevalence of substance use is associated with the onset of drug use and transitioning into greater involvement with drug use. ObjectiveTo use cross-national data to examine time-space variation in cohort-level drug use to assess its associations with onset and transitions across stages of drug use, abuse, dependence, and remission. Design, Setting, and ParticipantsThe World Health Organization World Mental Health Surveys carried out cross-sectional general population surveys in 25 countries using a consistent research protocol and assessment instrument. Adults from representative household samples were interviewed face-to-face in the community in relation to drug use disorders. The surveys were conducted between 2001 and 2015. Data analysis was performed from July 2017 to July 2018. Main Outcomes and MeasuresData on timing of onset of lifetime drug use, DSM-IV drug use disorders, and remission from these disorders was assessed using the Composite International Diagnostic Interview. Associations of cohort-level alcohol prevalence and drug use prevalence were examined as factors associated with these transitions. ResultsAmong the 90027 respondents (48.1% [SE, 0.2%] men; mean [SE] age, 42.1 [0.1] years), 1 in 4 (24.8% [SE, 0.2%]) reported either illicit drug use or extramedical use of prescription drugs at some point in their lifetime, but with substantial time-space variation in this prevalence. Among users, 9.1% (SE, 0.2%) met lifetime criteria for abuse, and 5.0% (SE, 0.2%) met criteria for dependence. Individuals who used 2 or more drugs had an increased risk of both abuse (odds ratio, 5.17 [95% CI, 4.66-5.73]; P<.001) and dependence (odds ratio, 5.99 [95% CI, 5.02-7.16]; P<.001) and reduced probability of remission from abuse (odds ratio, 0.86 [95% CI, 0.76-0.98]; P=.02). Birth cohort prevalence of drug use was also significantly associated with both initiation and illicit drug use transitions; for example, after controlling for individuals' experience of substance use and demographics, for each additional 10% of an individual's cohort using alcohol, a person's odds of initiating drug use increased by 28% (odds ratio, 1.28 [95% CI, 1.26-1.31]). Each 10% increase in a cohort's use of drug increased individual risk by 12% (1.12 [95% CI, 1.11-1.14]). Conclusions and RelevanceBirth cohort substance use is associated with drug use involvement beyond the outcomes of individual histories of alcohol and other drug use. This has important implications for understanding pathways into and out of problematic drug use.
机译:重要的实证研究已经研究了物质使用的群体水平普遍性的程度与药物使用的发作相关,并转变为吸毒的更大累录。 ObjectiveTo使用跨国数据来检查群组级药物用途的时空变化,以评估其在药物使用,滥用,依赖和缓解阶段的发作和过渡的关联。世界卫生组织世界心理健康调查设计,设定和参与者,使用一致的研究方案和评估工具在25个国家进行了横断面一般人口调查。来自代表性家庭样本的成年人在社区面对面接受了与吸毒障碍有关的面对面。调查在2001年至2015年间进行。使用复合材料评估数据分析于2017年7月至2018年7月。国际诊断面试。群组级酒精患病率和药物使用的关联被检查为与这些过渡相关的因素。结果Themong 90027受访者(48.1%[SE,0.2%]男性;均值[se]年龄,42.1 [0.1]年),1 in 4(24.8%[SE,0.2%])报告了非法药物使用或鉴别使用处方药在寿命的某些时候,但在这种流行中具有大量的时空变化。在用户中,9.1%(SE,0.2%)达到滥用的终身标准,5.0%(SE,0.2%)符合依赖的标准。使用2种或更多药物的个体具有增加的滥用风险(赔率比,5.17 [95%CI,4.66-5.73]; p <.001)和依赖性(差距比例,5.99 [95%CI,5.02-7.16] ; p <.001)和降低滥用的缓解概率(差距,0.86 [95%CI,0.76-0.98]; p = .02)。出生队列吸毒患病率也与发起和非法药物使用过渡的显着相关;例如,在控制个人的物质使用和人口统计学经验之后,对于使用酒精的每个额外10%的个人队列,引发药物使用的几率增加了28%(差距比例为1.28 [95%CI,1.26] 1.31])。群组的每10%的增加的药物的使用增加了个体风险12%(1.12 [95%CI,1.11-1.14])。结论和相关性群体物质使用与药物使用涉及的药物使用,超出了单个酒精和其他药物使用的历史的结果。这对理解途径和出于问题的药物使用具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号